2089253-13-2
2089253-13-2
Chemical Structure
LNP Lipid-1
- CAS No.: 2089253-13-2
- Formula:C46H91NO5
- Molecular Weight:738.22
IUPAC Name: henicosan-11-yl 6-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)hexanoate
InChIKey: YDXPMICNZYCJHE-UHFFFAOYSA-N
SMILES: O=C(CCCCCN(CCCCCC(OC(CCCCCCCCCC)CCCCCCCCCC)=O)CCO)OCCCCCCCCCCC
Biological Activity: LNP Lipid-1 (Method B) is a lipid compound. LNP Lipid-1 is involved in the synthesis of lipid nanoparticles compositions. LNP Lipid-1 has potential applications in the transport of biologically active substances such as small molecule agents, proteins, and nucleic acids[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
LNP Lipid-1 | LNP Lipid-1 (Method B) is a lipid compound. LNP Lipid-1 is involved in the synthesis of lipid nanoparticles compositions. LNP Lipid-1 has potential applications in the transport of biologically active substances such as small molecule agents, proteins, and nucleic acids. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Benenato Kerry E, et al. Compounds and compositions for intracellular delivery of therapeutic agents. World Intellectual Property Organization. WO2020061367.
- [2]. Benenato K, et al. Polynucleotides encoding lipoprotein lipase for the treatment of hyperlipidemia. World Intellectual Property Organization. WO2017201333.
